| Trial ID: | L0820 |
| Source ID: | NCT01026363
|
| Associated Drug: |
Ergocalciferol
|
| Title: |
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Vitamin D Deficiency
|
| Interventions: |
DRUG: Ergocalciferol|DRUG: Calcitriol
|
| Outcome Measures: |
Primary: hCAP18 levels, 2 weeks | Secondary: 1,25-dihydroxyvitamin D, 2 weeks|25-hydroxyvitamin D, 2 weeks|calcium, 2 weeks|phosphorus, 2 weeks|Parathyroid hormone, 2 weeks|T-cell subsets, Measures of different types of T-cells, 2 weeks
|
| Sponsor/Collaborators: |
Sponsor: Massachusetts General Hospital | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Kidney Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-12
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-09-23
|
| Locations: |
Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01026363
|
